Adalimumab/etanercept/infliximab

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2012年 / 1432卷 / 1期
关键词：
D O I：
10.1007/s40278-012-0154-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [21] Response to Etanercept, but Not Infliximab or Adalimumab, Is Inversely Associated with Body Mass Index
    Maxwell, James R.
    Plant, Darren
    Barton, Anne
    Hyrich, Kimme L.
    Morgan, Ann W.
    Isaacs, John
    Wilson, Anthony G.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S157 - S157
  • [22] Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
    Alistair I Henry
    Haiping Gong
    Andrew M Nesbitt
    Journal of Translational Medicine, 9 (Suppl 2)
  • [23] Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept
    Shen, C
    Assche, GV
    Colpaert, S
    Maerten, P
    Geboes, K
    Rutgeerts, P
    Ceuppens, JL
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) : 251 - 258
  • [24] Infliximab, Etanercept, and Adalimumab switching in patients with rheumatoid arthritis in the CORRONA database
    Dabbous, O.
    Kremer, J.
    Rambharose, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Thomson, H.
    Domdey, A.
    Rahman, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
  • [25] Adalimumab, etanercept, and infliximab bind to soluble and transmembrane TNF with similar affinities
    Kaymakcalan, Z.
    Sakorafas, P.
    Bose, S.
    Scesney, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 458 - 458
  • [26] Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis
    Titos Arcos, Jose Carlos
    Hallal, Hacibe
    Robles, Mercedes
    Andrade, Raul J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2012, 104 (05) : 282 - 284
  • [27] Differential TNF-neutralizing potencies of adalimumab, etanercept and infliximab.
    Kaymakcalan, Zehra
    Kalghatgi, Leena
    Xiang, Limin
    CLINICAL IMMUNOLOGY, 2006, 119 : S77 - S78
  • [28] Differing Contribution of Methotrexate Polyglutamation to Infliximab and Adalimumab Exposure As Compared to Etanercept
    Dervieux, Thierry
    Kremer, Joel M.
    O'Malley, Tyler
    Kivitz, Alan J.
    Conklin, John
    Weinblatt, Michael
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [29] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [30] Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis
    Gladman, Dafna D.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (10): : 510 - 511
12345